{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:57:23Z","timestamp":1792789043740,"version":"4.5.0"},"reference-count":31,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Health and Medical Research Council of Australia","award":["APP2009800"],"award-info":[{"award-number":["APP2009800"]}],"id":[{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"crossref"}]},{"award":["APP2009800"],"award-info":[{"award-number":["APP2009800"]}],"id":[{"id":"https:\/\/ror.org\/011kf5r70","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Introduction: The ARCAD-CRC nomogram predicts 1-year survival in clinical trial populations with stage 4 colorectal cancer (CRC). This study evaluated its performance in a real-world cohort. Methods: Patients with stage 4 CRC were identified from the Flatiron database. A multivariable Cox proportional hazards model for overall survival was applied to fit the reduced model derived from the published full ARCAD nomogram, as some variables were unavailable in the database. Validation of the reduced model used C-index, while predictive performance was assessed using time-dependent ROC analysis and calibration in the Flatiron real-world cohort (FRWC). Results: A total 9710 patients, including 5740 deceased, were analyzed. The FRWC was older (64 vs. 62 years) and had poorer ECOG-PS (15% vs. 4% with ECOG 2+) compared to the ARCAD cohort. The reduced nomogram\u2019s calibration was comparable to the full model (C-index 0.67 vs. 0.68). In the FRWC, the reduced nomogram showed good discrimination, with time-dependent AUROC at the 12-month time horizon of 0.741 (95% CI 0.729\u20130.753). Calibration plots indicated the reduced ARCAD-CRC nomogram performed quantitively well with a calibration slope of 1.010 (95% CI 0.966\u20131.054). The calibration intercept was \u22120.160 (95% CI \u22120.189, \u22120.131), indicating systematic underestimation of 1-year survival in the FRWC. The predicted and observed 1-year OS using the reduced ARCAD nomogram in the FRWC were 0.640 (95% CI 0.637, 0.644) and 0.694 (95% CI 0.684\u20130.703), respectively. Conclusions: Our findings show that the ARCAD-CRC nomogram is a useful tool for predicting 1-year survival in a real-world cohort. The observed underestimation of survival may be due to advances in CRC treatments, as the FRWC cohort (2013\u20132020) was collected later than the original ARCAD cohort (1997\u20132012).<\/jats:p>","DOI":"10.3390\/cancers18183031","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:50:03Z","timestamp":1789995003000},"page":"3031","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["External Validation of the ARCAD Nomogram in a Real-World Cohort with Stage 4 Colorectal Cancer"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6793-0008","authenticated-orcid":false,"given":"James","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA"},{"name":"H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Jiannong","family":"Li","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4594-6601","authenticated-orcid":false,"given":"Michael J.","family":"Schell","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Pablo","family":"Gonzalez Ginestet","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, University of Sydney, 119-143 Missenden Rd, Sydney, NSW 2050, Australia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6624-0782","authenticated-orcid":false,"given":"John Raymond","family":"Zalcberg","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Alfred Health and School of Public Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3740-7563","authenticated-orcid":false,"given":"R John","family":"Simes","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, University of Sydney, 119-143 Missenden Rd, Sydney, NSW 2050, Australia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Ian","family":"Marschner","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, University of Sydney, 119-143 Missenden Rd, Sydney, NSW 2050, Australia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Richard D.","family":"Kim","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9028-8682","authenticated-orcid":false,"given":"Katrin Marie","family":"Sjoquist","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, University of Sydney, 119-143 Missenden Rd, Sydney, NSW 2050, Australia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","unstructured":"(2026, August 20). Cancer of the Colon and Rectum\u2014Cancer Stat Facts. SEER, Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/colorect.html."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/bjc.2011.19","article-title":"BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer","volume":"104","author":"Yokota","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2123::AID-CNCR6>3.0.CO;2-W","article-title":"Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients","volume":"82","author":"Yancik","year":"1998","journal-title":"Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1046\/j.0007-1323.2001.01819.x","article-title":"Gender differences in long-term survival of patients with colorectal cancer","volume":"88","author":"Wichmann","year":"2001","journal-title":"J. Br. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"djw272","DOI":"10.1093\/jnci\/djw272","article-title":"Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer","volume":"109","author":"Taieb","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s00268-010-0891-8","article-title":"Systematic Review of Prognostic Factors Related to Overall Survival in Patients with Stage IV Colorectal Cancer and Unresectable Metastases","volume":"35","author":"Stillwell","year":"2011","journal-title":"World J. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How To Build and Interpret a Nomogram for Cancer Prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_10","first-page":"030006052110150","article-title":"Development and external validation of a nomogram predicting overall survival after curative resection of colon cancer","volume":"49","author":"Wang","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/jnci\/djx253","article-title":"Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project","volume":"110","author":"Sjoquist","year":"2018","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/EDE.0000000000000564","article-title":"Biases in Randomized Trials","volume":"28","author":"Mansournia","year":"2017","journal-title":"Epidemiology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"djx187","DOI":"10.1093\/jnci\/djx187","article-title":"Real-world Data for Clinical Evidence Generation in Oncology","volume":"109","author":"Khozin","year":"2017","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.6004\/jnccn.2020.7578","article-title":"Performance Status Restriction in Phase III Cancer Clinical Trials","volume":"18","author":"Kouzy","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Hamers, P.A.H., Wensink, G.E., Van Smeden, M., Vink, G.R., Smabers, L.P., Lunenberg, R.A., Lacl\u00e9, M.M., Koopman, M., May, A.M., and Roodhart, J.M.L. (2022). External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine\/Tipiracil in Daily Practice. Cancers, 14.","DOI":"10.3390\/cancers14205094"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","article-title":"MissForest\u2014Non-parametric missing value imputation for mixed-type data","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/gastro\/goaa022","article-title":"BRAF and KRAS mutations in metastatic colorectal cancer: Future perspectives for personalized therapy","volume":"8","author":"Li","year":"2020","journal-title":"Gastroenterol. Rep."},{"key":"ref_18","first-page":"501","article-title":"Regression Modeling Strategies","volume":"64","author":"Steyerberg","year":"2011","journal-title":"Rev. Esp. Cardiol. Engl. Ed."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ckj\/sfaa188","article-title":"External validation of prognostic models: What, why, how, when and where?","volume":"14","author":"Ramspek","year":"2021","journal-title":"Clin. Kidney J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/ejcts\/ezy180","article-title":"Statistical Primer: Developing and validating a risk prediction model\u2020","volume":"54","author":"Grant","year":"2018","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1200\/JCO.2011.36.5080","article-title":"Predicting Survival After Curative Colectomy for Cancer: Individualizing Colon Cancer Staging","volume":"29","author":"Weiser","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"S457","DOI":"10.1016\/j.annonc.2020.08.622","article-title":"512P External validity of the ARCAD nomogram in a real-life population of older patients with unresectable advanced colorectal cancer","volume":"31","author":"Tournigand","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/annonc\/mdf034","article-title":"Clinical determinants of survival in patients with 5-fluorouracil- based treatment for metastatic colorectal cancer: Results of a multivariate analysis of 3825 patients","volume":"13","author":"Cunningham","year":"2002","journal-title":"Ann. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1200\/JCO-24-01968","article-title":"Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Canc\u00e9rologie Digestive Database","volume":"43","author":"Bachet","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(24)02848-4","article-title":"Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): A randomised, open-label, phase 3 trial","volume":"405","author":"Elez","year":"2025","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in Microsatellite-Instability\u2013High Advanced Colorectal Cancer","volume":"383","author":"Shiu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2024.42.16_suppl.3503","article-title":"Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) as first-line (1L) treatment for microsatellite instability-high\/mismatch repair-deficient (MSI-H\/dMMR) metastatic colorectal cancer (mCRC): Expanded efficacy analysis from CheckMate 8HW","volume":"42","author":"Lenz","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa2501912","article-title":"Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer","volume":"392","author":"Elez","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1056\/NEJMoa2308795","article-title":"Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C","volume":"389","author":"Fakih","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_30","first-page":"LBA3503(2026)","article-title":"BREAKWATER: Progression-free and overall survival analyses of first-line (1L) encorafenib + cetuximab (EC) + FOLFIRI in BRAF V600E-mutant metastatic colorectal cancer (mCRC)","volume":"44","author":"Kopetz","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa2212419","article-title":"Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C","volume":"388","author":"Yaeger","year":"2023","journal-title":"N. Engl. J. Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/3031\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:17:22Z","timestamp":1790237842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/3031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":31,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18183031"],"URL":"https:\/\/doi.org\/10.3390\/cancers18183031","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}